Matinas BioPharma Holdings (MTNB) Short-term Investments (2016 - 2026)
Matinas BioPharma Holdings (MTNB) posted quarterly Short-term Investments of $50000.0 for Q1 2026, little changed year-over-year from $50000.0 in Q1 2025, and little changed quarter-over-quarter from $50000.0 in Q4 2025.
Matinas BioPharma Holdings (MTNB) Short-term Investments (2016 - 2026) Analysis & Trends
Matinas BioPharma Holdings (MTNB) has reported Short-term Investments for 11 consecutive years, with $50000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Short-term Investments changed 0.0% year-over-year to $50000.0; the TTM figure through Mar 2026 stood at $50000.0 (changed 0.0% YoY), while the FY2025 annual figure was $50000.0, changed 0.0% from the prior year.
- Short-term Investments held at $50000.0 in Q1 2026 per MTNB's latest filing, from $50000.0 in the prior quarter.
- Across five years, Short-term Investments topped out at $28.1 million in Q2 2022 and bottomed at $50000.0 in Q4 2022.
- Historically, Short-term Investments has averaged $5.2 million across 5 years, with a median of $50000.0 in 2022.
- Annual changes were most pronounced in 2022 — Short-term Investments tumbled 99.83% — and 2023, when it changed 0.0%.
- Matinas BioPharma Holdings' Short-term Investments stood at $50000.0 in 2022, then changed by 0.0% to $50000.0 in 2023, then changed by 0.0% to $50000.0 in 2024, then changed by 0.0% to $50000.0 in 2025, then changed by 0.0% to $50000.0 in 2026.
- Business Quant data shows MTNB's Short-term Investments at $50000.0 in Q1 2026, $50000.0 in Q4 2025, and $50000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Matinas BioPharma Holdings | 1.25 Mn | 437,566.66 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 50,000.00 |
| Mar 31, 2026 | 50,000.00 |
| Dec 31, 2025 | 50,000.00 |
| Sep 30, 2025 | 50,000.00 |
| Jun 30, 2025 | 50,000.00 |
| Mar 31, 2025 | 50,000.00 |
| Dec 31, 2024 | 50,000.00 |
| Sep 30, 2024 | 50,000.00 |
| Jun 30, 2024 | 50,000.00 |
| Mar 31, 2024 | 50,000.00 |
| Dec 31, 2023 | 50,000.00 |
| Sep 30, 2023 | 50,000.00 |
| Jun 30, 2023 | 12.77 Mn |
| Mar 31, 2023 | 50,000.00 |
| Dec 31, 2022 | 50,000.00 |
| Sep 30, 2022 | 21.88 Mn |
| Jun 30, 2022 | 28.10 Mn |
| Mar 31, 2022 | 24.50 Mn |
| Dec 31, 2021 | 28.59 Mn |
| Sep 30, 2021 | 28.90 Mn |